Eligibility Criteria

To be considered for the scheme, applicants must meet certain common criteria and group-specific requirements.

Common Eligibility for All Applicants

• You must be a manufacturer of pharmaceutical goods registered in India.
• Your manufacturing activities must be for eligible pharmaceutical products listed under the scheme's three categories.
• You cannot claim incentives for the same product under this scheme and the PLI Scheme for Bulk Drugs or any other PLI scheme.

Group A Applicants

• Your Global Manufacturing Revenue for pharma goods or in-vitro diagnostic medical devices should be ₹50,000 crores or more in FY 2019-20.
• You need to achieve a minimum cumulative investment of ₹1,000 crores over 5 years.
• You must achieve a minimum turnover of ₹50 crores from eligible products in the first year (FY 2022-23).

Group B Applicants

• Your Global Manufacturing Revenue for pharma goods or in-vitro diagnostic medical devices should be between ₹500 crores and ₹5,000 crores in FY 2019-20.
• You need to achieve a minimum cumulative investment of ₹250 crores over 5 years.
• You must achieve a minimum turnover of ₹10 crores from eligible products in the first year (FY 2022-23).

Group C Applicants

• Your Global Manufacturing Revenue for pharma goods or in-vitro diagnostic medical devices should be less than ₹500 crores in FY 2019-20.
• You need to achieve a minimum cumulative investment of ₹50 crores over 5 years.
• You must achieve a minimum turnover of ₹1 crore from eligible products in the first year (FY 2022-23).

Group C (MSME) Applicants

• You must be classified under the Micro, Small and Medium Enterprises (MSME) category within Group C.
• You need to achieve the committed investment amount over a period of 5 years.
• You must achieve a minimum turnover of ₹50 lakhs from eligible products in the first year (FY 2022-23).

Continuation Criteria

• To keep receiving incentives from FY 2023-24 onwards, you must achieve a 7% growth in sales compared to the previous financial year.